| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,544,753 | 1,558,111 | 1,377,812 | 1,269,107 | | Cost of Revenue |
-
|
-
|
-
| 3,475,208 | | | Gross Profit |
-
| 1,558,111 | 1,377,812 | (2,206,101) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (821,353) | 1,407,115 | 1,137,315 | (2,316,993) | | Non Recurring |
-
|
-
|
-
| 533,324 | | Others | 2,239,469 | (17,130) | 141,393 | (258,159) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 81,197 | 168,126 | 99,104 | (164,273) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 97,415 | | Earnings Before Interest And Taxes | 126,637 | 168,126 | 99,104 | (66,858) | | Interest Expense | 13,636 | 15,713 | 16,091 | 22,937 | | Income Before Tax | 113,001 | 152,413 | 83,013 | (89,795) | | Income Tax Expense | 41,719 | 58,478 | 28,055 | (32,114) | | Minority Interest | (58,516) |
-
|
-
| (9,222) | | | | Net Income From Continuing Ops | 71,282 | 93,935 | 54,958 | (66,903) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,766 | 93,935 | 54,958 | (66,903) | | Preferred Stock And Other Adjustments | 42,596 | (23,663) | (18,933) |
-
| | | Net Income Applicable To Common Shares | $55,362 | $70,272 | $36,025 | ($66,903) |
|
1.52% Nasdaq 
Income Statement
